TCM
GEVA

Tekla Capital Management’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Tekla Capital Management’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-198,689
Closed -$19.4M – 143
2015
Q1 		$19.4M Sell
198,689
-24,331
-11% -$2.58M 0.77% 34
2014
Q4 		$20.7M Hold
223,020
– – 0.97% 27
2014
Q3 		$15.3M Buy
+223,020
New +$16M 0.72% 33

Tekla Capital Management's GEVA Position: Q2 2015 in Review

Tekla Capital Management sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 198,689 shares — an estimated $19.4M sold.

Tekla Capital Management first reported a position in GEVA in Q3 2014 and held it in 3 quarters. The position peaked at $20.7M in Q4 2014. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • Tekla Capital Management reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Tekla Capital Management sold 198,689 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $19.4M.
  • Tekla Capital Management first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q3 2014 and held it in 3 quarters.
  • Tekla Capital Management's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $20.7M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on Tekla Capital Management's 13F filing for Q2 2015, filed 12 Aug 2015.